Gillian Pearce

1.3k total citations
28 papers, 967 citations indexed

About

Gillian Pearce is a scholar working on Psychiatry and Mental health, Pharmacology and Infectious Diseases. According to data from OpenAlex, Gillian Pearce has authored 28 papers receiving a total of 967 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Psychiatry and Mental health, 7 papers in Pharmacology and 5 papers in Infectious Diseases. Recurrent topics in Gillian Pearce's work include Schizophrenia research and treatment (8 papers), Electroconvulsive Therapy Studies (5 papers) and HIV Research and Treatment (4 papers). Gillian Pearce is often cited by papers focused on Schizophrenia research and treatment (8 papers), Electroconvulsive Therapy Studies (5 papers) and HIV Research and Treatment (4 papers). Gillian Pearce collaborates with scholars based in United Kingdom, Germany and United States. Gillian Pearce's co-authors include Ronald D. Mann, Shayne N. Freemantle, W.H.W. Inman, Lynda Wilton, Lynda V. Wilton, Pipasha Biswas, Kiyoshi Kubota, Saad Shakir, Richard M. Martin and Deborah Layton and has published in prestigious journals such as The British Journal of Psychiatry, Journal of Clinical Epidemiology and AIDS.

In The Last Decade

Gillian Pearce

28 papers receiving 881 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gillian Pearce United Kingdom 16 274 224 174 161 114 28 967
Cynthia Kornegay United States 11 105 0.4× 69 0.3× 87 0.5× 82 0.5× 93 0.8× 16 753
Neil Roskell United States 17 140 0.5× 56 0.3× 132 0.8× 91 0.6× 64 0.6× 31 913
Darius A. Rastegar United States 18 188 0.7× 67 0.3× 48 0.3× 67 0.4× 100 0.9× 47 851
Milou‐Daniel Drici France 21 264 1.0× 19 0.1× 92 0.5× 136 0.8× 72 0.6× 73 1.6k
Kathleen D. Lake United States 23 155 0.6× 15 0.1× 214 1.2× 263 1.6× 219 1.9× 66 2.0k
Seonaid Nolan Canada 19 155 0.6× 37 0.2× 49 0.3× 139 0.9× 201 1.8× 67 1.3k
Joseph D. Sapira United States 18 43 0.2× 22 0.1× 65 0.4× 53 0.3× 134 1.2× 44 906
Sabrina Sales Martínez United States 15 485 1.8× 214 1.0× 22 0.1× 62 0.4× 63 0.6× 66 1.1k
María José Ferrer Spain 16 409 1.5× 271 1.2× 57 0.3× 13 0.1× 52 0.5× 42 1.0k
Marie‐Josée Brouillette Canada 15 267 1.0× 167 0.7× 105 0.6× 73 0.5× 53 0.5× 69 596

Countries citing papers authored by Gillian Pearce

Since Specialization
Citations

This map shows the geographic impact of Gillian Pearce's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gillian Pearce with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gillian Pearce more than expected).

Fields of papers citing papers by Gillian Pearce

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gillian Pearce. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gillian Pearce. The network helps show where Gillian Pearce may publish in the future.

Co-authorship network of co-authors of Gillian Pearce

This figure shows the co-authorship network connecting the top 25 collaborators of Gillian Pearce. A scholar is included among the top collaborators of Gillian Pearce based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gillian Pearce. Gillian Pearce is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Layton, Deborah, David W. Clark, Gillian Pearce, & Saad Shakir. (2001). Is there an association between selective serotonin reuptake inhibitors and risk of abnormal bleeding?. European Journal of Clinical Pharmacology. 57(2). 167–176. 52 indexed citations
2.
Layton, Deborah, Gillian Pearce, & Saad Shakir. (2001). Safety Profile of Tolterodine as Used in General Practice in England. Drug Safety. 24(9). 703–713. 30 indexed citations
3.
Clark, David W. J., Deborah Layton, Lynda V. Wilton, Gillian Pearce, & Saad Shakir. (2001). Profiles of Hepatic and Dysrhythmic Cardiovascular Events Following Use of Fluoroquinolone Antibacterials. Drug Safety. 24(15). 1143–1154. 22 indexed citations
4.
Biswas, Pipasha, Lynda V. Wilton, Gillian Pearce, Shayne N. Freemantle, & Saad Shakir. (2001). The pharmacovigilance of olanzapine: results of a post-marketing surveillance study on 8858 patients in England. Journal of Psychopharmacology. 15(4). 265–271. 48 indexed citations
5.
Miller, Veronica, Mounir Ait‐Khaled, Christopher Stone, et al.. (2000). HIV-1 reverse transcriptase (RT) genotype and susceptibility to RT inhibitors during abacavir monotherapy and combination therapy. AIDS. 14(2). 163–171. 107 indexed citations
6.
Wilton, Lynda V., Gillian Pearce, & Ronald D. Mann. (1999). The use of newly marketed drugs in children and adolescents prescribed in general practice. Pharmacoepidemiology and Drug Safety. 8(S1). S37–S45. 21 indexed citations
7.
Wilton, Lynda V., Gillian Pearce, & Ronald D. Mann. (1999). The use of newly marketed drugs in children and adolescents prescribed in general practice. Pharmacoepidemiology and Drug Safety. 8(S1). S37–S45. 2 indexed citations
8.
Freemantle, Shayne N., et al.. (1999). Safety profile of nicorandil—prescription-event monitoring (PEM) study. Pharmacoepidemiology and Drug Safety. 8(3). 197–205. 29 indexed citations
9.
Martin, Richard M., Pipasha Biswas, Shayne N. Freemantle, Gillian Pearce, & Ronald D. Mann. (1998). Age and sex distribution of suspected adverse drug reactions to newly marketed drugs in general practice in England: analysis of 48 cohort studies. British Journal of Clinical Pharmacology. 46(5). 505–511. 150 indexed citations
10.
Katlama, Christine, Thomas Harrer, Patrice Massip, et al.. (1998). A dose-ranging study to evaluate the safety and efficacy of abacavir alone or in combination with zidovudine and lamivudine in antiretroviral treatment-naive subjects. AIDS. 12(16). F197–F202. 74 indexed citations
11.
Mackay, F. J., Nicholas Dunn, Lynda V. Wilton, et al.. (1997). A comparison of fluvoxamine, fluoxetine, sertraline and paroxetine examined by observational cohort studies. Pharmacoepidemiology and Drug Safety. 6(4). 235–246. 74 indexed citations
12.
Miller, Veronica, Thomas Stark, J. De Crée, et al.. (1996). Virological and immunological analysis of a triple combination pilot study with loviride, lamivudine and zidovudine in HIV-1-infected patients. AIDS. 10(5). F1–F7. 72 indexed citations
13.
Mann, Ronald D., Kiyoshi Kubota, Gillian Pearce, & Lynda Wilton. (1996). Salmeterol: A study by Prescription Event Monitoring in a UK cohort of 15,407 patients. Journal of Clinical Epidemiology. 49(2). 247–250. 76 indexed citations
14.
Edwards, Jeffrey G., W.H.W. Inman, Lynda Wilton, & Gillian Pearce. (1994). Prescription-Event Monitoring of 10401 Patients Treated with Fluvoxamine. The British Journal of Psychiatry. 164(3). 387–395. 36 indexed citations
15.
Inman, W.H.W., Kiyoshi Kubota, Gillian Pearce, & Lynda Wilton. (1993). PEM report number 6. Paroxetine. Pharmacoepidemiology and Drug Safety. 2(4-5). 393–422. 14 indexed citations
16.
Inman, W.H.W., Kiyoshi Kubota, Gillian Pearce, & Lynda Wilton. (1993). PEM report number 7. Itraconazole. Pharmacoepidemiology and Drug Safety. 2(4-5). 423–443. 11 indexed citations
17.
Inman, W.H.W., et al.. (1993). PEM report number 10. Zopiclone. Pharmacoepidemiology and Drug Safety. 2(4-5). 499–521. 18 indexed citations
18.
Inman, W.H.W., Kiyoshi Kubota, Gillian Pearce, & Lynda Wilton. (1993). PEM report number 4. Ciprofloxacin. Pharmacoepidemiology and Drug Safety. 2(4-5). 341–364. 3 indexed citations
19.
Edwards, J. Guy, W.H.W. Inman, Gillian Pearce, & Nigel S. B. Rawson. (1991). Prescription-Event Monitoring of 10 895 Patients Treated with Alprazolam. The British Journal of Psychiatry. 158(3). 387–392. 15 indexed citations
20.
Rawson, Nigel S. B., Gillian Pearce, & W.H.W. Inman. (1990). Prescription-event monitoring: Methodology and recent progress. Journal of Clinical Epidemiology. 43(5). 509–522. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cynthia Kornegay Breakdown of academic impact, for papers by Neil Roskell Breakdown of academic impact, for papers by Darius A. Rastegar Breakdown of academic impact, for papers by Milou‐Daniel Drici Breakdown of academic impact, for papers by Kathleen D. Lake Breakdown of academic impact, for papers by Seonaid Nolan Breakdown of academic impact, for papers by Joseph D. Sapira Breakdown of academic impact, for papers by Sabrina Sales Martínez Breakdown of academic impact, for papers by María José Ferrer Breakdown of academic impact, for papers by Marie‐Josée Brouillette
Rankless by CCL
2026